IDNA Genomics Public Ltd (CYS:IDNA)

IDNA Genomics Public Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Mar 11, 2026	Dec 31, 2024	Dec 31, 2023
Market Capitalization	63	76	76
Enterprise Value	65	79	-
Last Close Price	22.80	27.60	27.60
PS Ratio	122.75	159.33	154.54
PB Ratio	-38.63	-114.72	31.70
EV/Sales Ratio	126.88	165.71	-
Debt / Equity Ratio	-1.55	-4.08	1.31
Net Debt / Equity Ratio	-1.45	-3.47	1.27
Net Debt / EBITDA Ratio	-1.44	-1.76	-2.71
Net Debt / FCF Ratio	-0.85	-0.91	-235.90
Asset Turnover	-	0.09	-
Inventory Turnover	-	1.49	-
Quick Ratio	0.21	0.36	0.20
Current Ratio	0.29	0.47	0.29
Return on Equity (ROE)	-	-341.88%	-
Return on Assets (ROA)	-	-17.80%	-
Return on Capital Employed (ROCE)	244.50%	-325.00%	-23.00%
Earnings Yield	-3.99%	-3.31%	-1.76%
FCF Yield	-4.40%	-3.32%	-0.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.